journal article·2022-12-14Open access

Development and Characterization of Bioinspired Lipid Raft Nanovesicles for Therapeutic Applications

Lalithasri Ramasubramanian, Harsha Jyothi, Leora Goldbloom-Helzner, Brandon M. Light, Priyadarsini Kumar, Randy P. Carney, Diana L. Farmer, Aijun Wang

ACS Applied Materials & Interfaces· Volume 14· Issue 49

Abstract

Lipid rafts are highly ordered regions of the plasma membrane enriched in signaling proteins and lipids. Their biological potential is realized in exosomes, a subclass of extracellular vesicles (EVs) that originate from the lipid raft domains. Previous studies have shown that EVs derived from human placental mesenchymal stromal cells (PMSCs) possess strong neuroprotective and angiogenic properties. However, clinical translation of EVs is challenged by very low, impure, and heterogeneous yields. Therefore, in this study, lipid rafts are validated as a functional biomaterial that can recapitulate the exosomal membrane and then be synthesized into biomimetic nanovesicles. Lipidomic and proteomic analyses show that lipid raft isolates retain functional lipids and proteins comparable to PMSC-EV membranes. PMSC-derived lipid raft nanovesicles (LRNVs) are then synthesized at high yields using a facile, extrusion-based methodology. Evaluation of biological properties reveals that LRNVs can promote neurogenesis and angiogenesis through modulation of lipid raft-dependent signaling pathways. A proof-of-concept methodology further shows that LRNVs could be loaded with proteins or other bioactive cargo for greater disease-specific functionalities, thus presenting a novel type of biomimetic nanovesicles that can be leveraged as targeted therapeutics for regenerative medicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Circular RNAs in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States

Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Sacramento, California 95817, United States

Department of Biomedical Engineering, University of California-Davis, Davis, California 95616, United States

Funding

U.S. Department of Health and Human Services · Shriners Hospitals for Children · California Institute for Regenerative Medicine · Tobacco-Related Disease Research Program

References (63)

Show source-provided references
1. 10.1194/jlr.TR11900038310.1194/jlr.TR119000383 ↗
2. 10.1194/jlr.R200021-JLR20010.1194/jlr.R200021-JLR200 ↗
3. 10.1016/S1937-6448(10)82003-910.1016/S1937-6448(10)82003-9 ↗
4. 10.1128/MCB.19.11.728910.1128/MCB.19.11.7289 ↗
5. 10.1016/S1521-6616(03)00097-410.1016/S1521-6616(03)00097-4 ↗
6. 10.1074/jbc.M30644020010.1074/jbc.M306440200 ↗
7. 10.1016/j.cellsig.2006.12.00310.1016/j.cellsig.2006.12.003 ↗
8. Sangiorgio V. · Ital. J. Biochem. · 2004 · 53 · 98
9. 10.1074/jbc.271.17.1029910.1074/jbc.271.17.10299 ↗
10. 10.3892/ol.2016.530710.3892/ol.2016.5307 ↗
11. 10.1016/j.bbamcr.2005.05.00510.1016/j.bbamcr.2005.05.005 ↗
12. 10.1038/3503605210.1038/35036052 ↗
13. 10.3402/jev.v2i0.2261410.3402/jev.v2i0.22614 ↗
14. 10.1038/nri85510.1038/nri855 ↗
15. 10.3389/fimmu.2014.0060810.3389/fimmu.2014.00608 ↗
16. 10.1161/CIRCRESAHA.116.31055710.1161/CIRCRESAHA.116.310557 ↗
17. 10.1016/j.jcyt.2015.11.00910.1016/j.jcyt.2015.11.009 ↗
18. 10.1016/j.ymthe.2018.02.02010.1016/j.ymthe.2018.02.020 ↗
19. 10.1096/fj.201800972R10.1096/fj.201800972R ↗
20. 10.1016/j.immuni.2014.08.00810.1016/j.immuni.2014.08.008 ↗
21. 10.3390/cells812149710.3390/cells8121497 ↗
22. 10.1063/1.508712210.1063/1.5087122 ↗
23. 10.1186/s13578-019-0282-210.1186/s13578-019-0282-2 ↗
24. 10.1134/S000629792002005410.1134/S0006297920020054 ↗
25. 10.3389/fbioe.2020.0063310.3389/fbioe.2020.00633 ↗
26. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
27. 10.1186/s12859-015-0611-310.1186/s12859-015-0611-3 ↗
28. 10.1021/acsomega.0c0158210.1021/acsomega.0c01582 ↗
29. 10.1073/pnas.050879310310.1073/pnas.0508793103 ↗
30. 10.1093/glycob/cwl02510.1093/glycob/cwl025 ↗
31. 10.1016/j.bbrc.2010.08.06610.1016/j.bbrc.2010.08.066 ↗
32. 10.1007/s10456-005-5612-910.1007/s10456-005-5612-9 ↗
33. 10.3988/jcn.2015.11.4.29710.3988/jcn.2015.11.4.297 ↗
34. 10.1016/S0074-7742(09)85026-510.1016/S0074-7742(09)85026-5 ↗
35. 10.3389/fnmol.2011.0005110.3389/fnmol.2011.00051 ↗
36. 10.1161/01.RES.0000022200.71892.9F10.1161/01.RES.0000022200.71892.9F ↗
37. 10.1007/s12195-016-0457-410.1007/s12195-016-0457-4 ↗
38. 10.3390/cells1009241310.3390/cells10092413 ↗
39. 10.1186/s12943-019-0963-910.1186/s12943-019-0963-9 ↗
40. 10.1194/jlr.R08391510.1194/jlr.R083915 ↗
41. 10.1016/j.addr.2020.03.00210.1016/j.addr.2020.03.002 ↗
42. 10.3402/jev.v5.3257010.3402/jev.v5.32570 ↗
43. 10.1002/jcp.2519110.1002/jcp.25191 ↗
44. 10.1007/s12274-021-3868-z10.1007/s12274-021-3868-z ↗
45. 10.1021/nn402232g10.1021/nn402232g ↗
46. 10.1016/0005-2736(91)90295-J10.1016/0005-2736(91)90295-J ↗
47. 10.1016/0005-2736(86)90302-010.1016/0005-2736(86)90302-0 ↗
48. 10.1113/jphysiol.2013.26406910.1113/jphysiol.2013.264069 ↗
49. 10.1002/jev2.1223810.1002/jev2.12238 ↗
50. 10.1007/s13238-018-0529-410.1007/s13238-018-0529-4 ↗
51. 10.1080/20013078.2017.135947810.1080/20013078.2017.1359478 ↗
52. 10.1016/j.ejpb.2021.11.01210.1016/j.ejpb.2021.11.012 ↗
53. 10.1038/srep3616210.1038/srep36162 ↗
54. 10.3402/jev.v3.2464110.3402/jev.v3.24641 ↗
55. 10.1016/S0169-409X(02)00226-010.1016/S0169-409X(02)00226-0 ↗
56. 10.1038/nrd103310.1038/nrd1033 ↗
57. 10.1002/smll.20130354010.1002/smll.201303540 ↗
58. 10.1016/j.jcyt.2017.03.00310.1016/j.jcyt.2017.03.003 ↗
59. 10.1016/j.jmb.2020.16674710.1016/j.jmb.2020.166747 ↗
60. 10.1002/pmic.20140051510.1002/pmic.201400515 ↗
61. 10.1080/20013078.2017.132145510.1080/20013078.2017.1321455 ↗
62. 10.1038/nprot.2008.21110.1038/nprot.2008.211 ↗
63. 10.1093/nar/gkn92310.1093/nar/gkn923 ↗